Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Concert Pharmaceutic (CNCE)

Concert Pharmaceutic (CNCE)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 255,807
  • Shares Outstanding, K 23,796
  • Annual Sales, $ 10,510 K
  • Annual Income, $ -56,020 K
  • 60-Month Beta 0.92
  • Price/Sales 24.76
  • Price/Cash Flow N/A
  • Price/Book 1.74

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate -0.92
  • Number of Estimates 4
  • High Estimate -0.87
  • Low Estimate -0.99
  • Prior Year -0.57
  • Growth Rate Est. (year over year) -61.40%

Price Performance

See More
Period Period Low Period High Performance
1-Month
10.54 +1.99%
on 06/21/19
12.46 -13.72%
on 06/28/19
-0.46 (-4.10%)
since 06/19/19
3-Month
9.21 +16.72%
on 04/22/19
12.46 -13.72%
on 06/28/19
+1.31 (+13.88%)
since 04/18/19
52-Week
9.21 +16.72%
on 04/22/19
17.86 -39.81%
on 08/03/18
-5.86 (-35.28%)
since 07/19/18

Most Recent Stories

More News
Downtrend Call Working As Concert Pharmace Stock Falls 25.8% (CNCE)

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on March 27th, 2019 at $13.66. In approximately 2 months, Concert Pharmace has returned 25.84% as of today's recent price of $10.13....

CNCE : 10.75 (-1.65%)
Concert Pharmaceuticals Completes Enrollment in Open Label Trial to Evaluate Once-Daily vs. Twice-Daily Dosing of CTP-543 in Patients with Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has completed patient enrollment of an open label clinical trial to evaluate once-daily compared to twice-daily...

CNCE : 10.75 (-1.65%)
Concert Pharmaceuticals Announces Initiation of New Open Label Trial to Evaluate Once-Daily vs. Twice-Daily Dosing of CTP-543 in Patients with Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it has initiated a second open label clinical trial to evaluate once-daily compared to twice-daily oral dosing of...

CNCE : 10.75 (-1.65%)
Concert Pharmaceuticals to Present at Upcoming Investor Conferences

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will participate at the following upcoming investor conferences:

CNCE : 10.75 (-1.65%)
Concert Pharmace Has Returned 20.2% Since SmarTrend Recommendation (CNCE)

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on March 27th, 2019 at $13.66. In approximately 1 month, Concert Pharmace has returned 20.20% as of today's recent price of $10.90.

CNCE : 10.75 (-1.65%)
Concert: 1Q Earnings Snapshot

LEXINGTON, Mass. (AP) _ Concert Pharmaceuticals Inc. (CNCE) on Thursday reported a loss of $21.8 million in its first quarter.

CNCE : 10.75 (-1.65%)
Concert Pharmaceuticals Reports First Quarter 2019 Financial Results

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today reported financial results for the first quarter of 2019.

CNCE : 10.75 (-1.65%)
24.6% Return Seen to Date on SmarTrend Concert Pharmace Call (CNCE)

SmarTrend identified a Downtrend for Concert Pharmace (NASDAQ:CNCE) on March 27th, 2019 at $13.66. In approximately 1 month, Concert Pharmace has returned 24.60% as of today's recent price of $10.30.

CNCE : 10.75 (-1.65%)
Concert Pharmaceuticals Names Jesper Hoiland to its Board of Directors

Concert Pharmaceuticals, Inc. (NASDAQ:CNCE) announced today that Jesper Hoiland has been appointed to its Board of Directors and will serve as a member of its Compensation Committee,...

CNCE : 10.75 (-1.65%)
RDUS : 22.44 (+0.27%)
Concert Pharmaceuticals to Report First Quarter 2019 Financial Results on May 2, 2019

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced that it will report its first quarter 2019 financial results on Thursday, May 2, 2019, before the U.S. financial markets...

CNCE : 10.75 (-1.65%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade CNCE with:

Business Summary

Concert Pharmaceuticals Inc. is a biopharmaceutical company. It is focused on applying its DCE Platform (R) to create novel small molecule drugs. The Company manufactures drugs in various therapeutic areas such as hot flashes, HIV, renal hepatic, neuropathic pain, MRSA infection, and schizophrenia, multiple...

See More

Key Turning Points

2nd Resistance Point 11.06
1st Resistance Point 10.90
Last Price 10.75
1st Support Level 10.64
2nd Support Level 10.54

See More

52-Week High 17.86
Fibonacci 61.8% 14.56
Fibonacci 50% 13.53
Fibonacci 38.2% 12.51
Last Price 10.75
52-Week Low 9.21

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar